MRI-based technologies for the assessment of patients with non-alcoholic fatty liver disease [DAP59].Published in:Health Technology Assessment, 2023, v. 27, n. 10, p. v, doi. 10.3310/KGJU3398By:Bresnahan, Rebecca;Duarte, Rui;Mahon, James;Beale, Sophie;Chaplin, Marty;Bhattacharyya, Devarshi;Houten, Rachel;Edwards, Katherine;Nevitt, Sarah;Maden, Michelle;Boland, AngelaPublication type:Article